Search

Search Constraints

You searched for: Author/Creator Felloussi, Zakia

Search Results

1. First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours. (July 2022)